Risk found unaffected by prolonged exposure to pioglitazone… According to a recent study of more than one million people published in Diabetologia, the diabetes medications pioglitazone (Actos) and rosiglitazone (Avandia) do not appear to have an association with bladder cancer. It is known that bladder tumors overexpress transcription factor called …
Read More »Monthly Archives: December 2014
Midlife Diabetes Could Increase Risk of Cognitive Decline
Poor glucose control speeds progression of dementia… A new study by researchers from Johns Hopkins Bloomberg School of Public Health in Baltimore, MD, suggests that a midlife diagnosis of diabetes may accelerate the rate of cognitive decline over the following 20 years. Elizabeth Selvin, PhD, and her research team analyzed …
Read More »GLP-1 Receptor Activation Modulates Appetite, Rewards-Related Brain Areas
Study shows decrease in food intake and food-related brain responses… GLP-1 receptor agonists, currently used for the treatment of type 2 diabetes (T2DM), improve glycemic control and stimulate satiety, leading to decreases in food intake and body weight. Researchers hypothesized that food intake reduction after GLP-1 receptor activation is mediated …
Read More »Liraglutide Gets EU Positive Opinion for Diabetics with Renal Disease
GLP-1 agonist found to improved glycemic control, resulted in weight loss in type 2 adults with moderate renal impairment…
Read More »Avoiding Malpractice Lawsuits in Diabetes Care
Because diabetes has the potential for serious complications and requires immense involvement by patients and physicians for successful outcomes, healthcare professionals who treat diabetic patients may be at risk for malpractice lawsuits. In a study of claims closed from 2007 to 2013, The Doctors Company identified four common allegations made …
Read More »Diabetes and Heart Disease Patients Should Avoid Traffic
Obese people and those with diabetes or heart disease should stay at home during rush hour, say scientists who warn ‘traffic pollution aggravates health conditions.’ The traffic fumes can not only aggravate existing poor health conditions, but have been found to contribute to the causes of diseases, they said. Air …
Read More »The Economic Burden of Elevated Blood Glucose Levels
A recent study showed that the diabetes "family" (diagnosed and undiagnosed diabetes [all ages], gestational diabetes, and prediabetes [adults]) cost the U.S. economy approximately $322 billion in 2012. This national estimate is 48% higher than the $218 billion estimate for 2007. Projected trends show that this number will increase due to …
Read More »Guiding Principles for Care of People with or at Risk for Diabetes
Guiding Principles for Care of People with or at Risk for Diabetes These Guiding Principles aim to identify and synthesize areas of general agreement among existing guidelines to help guide primary care providers and health care teams to deliver quality care to adults with or at risk for diabetes. Guiding Principles …
Read More »Biodel’s Glucagon Device
Biodel’s glucagon device speeds the preparation process for lifesaving glucagon — and minimizes confusion. Traditional glucagon kits require users to inject liquid from a syringe into a vial of glucagon powder, shake the vial until the liquid turns clear, and withdraw the liquid into the syringe before injecting. Biodel’s …
Read More »Letter from the Editor, #759
This past Thursday I got to see just how good cyclists can be when they’re in competition. I had qualified for the Florida Senior Games and was in Cape Coral to attempt to qualify for the nationals in the 60-64 age group. The first race was 20K and, although I …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.